SERA earnings date and last-quarter result: last quarter beat, P/E -3.20. Updated 2026-07-23.
Sera Prognostics (SERA) Research Hub
Sera Prognostics (SERA) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 2.04 USD (+0.49%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.20, market cap 0.08B. This hub links to the full technical, earnings and options research available for SERA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.04 USD (+0.49%) |
| 52-week range | 1.73 USD – 2.3 USD |
| Trend regime | Range |
| 14-day RSI | 48.4 (Neutral) |
| Trailing P/E | -3.20 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for SERA
Covered Call on SERA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SERA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SERA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
SERA technical analysis: range, last 2.04 USD, RSI 48.4, 52w range 1.73 USD–2.3 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SERA in?
Sera Prognostics (SERA) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is SERA in an uptrend or downtrend?
As of 2026-10-26, SERA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SERA's trailing P/E ratio?
SERA's trailing P/E is -3.20, with a market cap of 0.08B. See the earnings research page for full valuation detail.